Differentiating Among Incretin Agents for Type 2 Diabetes: Weighing the Evidence SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS SGLT2 INHIBITOR:…
